CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 289 enrolled
Drug / intervention
Diclofenac Sodium Active Topical Patch 1 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03277066
NCT03277066Phase 2Completed
CompareCT.gov

A 4-week, Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2 Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis (OA) of the Knee

Noven Pharmaceuticals, Inc.·interventional·Posted Sep 8, 2017·Updated Dec 23, 2021

In Brief

A Phase 2 clinical trial evaluating Diclofenac Sodium Active Topical Patch 1, Diclofenac Sodium Active Topical Patch 2, and 1 other intervention for Osteoarthritis of the Knee. Completed, enrolled 289 participants across 1 site.

Detailed Summary

A 4-week, Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2 Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) of the Knee

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of the Knee
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedSep 8, 2017
Enrollment StartSep 7, 2017
Primary CompletionSep 25, 2019
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 8.8 years ago

Interventions

Diclofenac Sodium Active Topical Patch 1drug

HP-5000 Active Topical Patch 1 were applied on subjects with Osteoarthritis of the knee(s)

Diclofenac Sodium Active Topical Patch 2drug

HP-5000 Active Topical Patch 2 were applied on subjects with Osteoarthritis of the knee(s)

Placebo patchdrug

Topical placebo patches were applied on subjects with Osteoarthritis of the knee(s)